Cite

HARVARD Citation

    Li, F. et al. (2020). CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency. Journal for immunotherapy of cancer. 8 (1), p. . [Online]. 
  
Back to record